J. Talbot

Best practices in bioassay development to support registration of biopharmaceuticals.

Elaine S E Stokes, J. R. White, M. Abodeely, 2019, BioTechniques.

Restoration of atypical protein kinase C ζ function in autosomal dominant polycystic kidney disease ameliorates disease progression

Markus M. Rinschen, T. Weimbs, O. Wessely, 2022, Proceedings of the National Academy of Sciences of the United States of America.

Polycystin-1 regulates STAT activity by a dual mechanism

J. Shillingford, T. Weimbs, T. Watnick, 2011, Proceedings of the National Academy of Sciences.

Regulation of STATs by polycystin-1 and their role in polycystic kidney disease

T. Weimbs, Erin E. Olsan, J. Talbot, 2013, JAK-STAT.

The cleaved cytoplasmic tail of polycystin-1 regulates Src-dependent STAT3 activation.

Markus M. Rinschen, B. Schermer, T. Weimbs, 2014, Journal of the American Society of Nephrology : JASN.

Measurement of Free Versus Total Therapeutic Monoclonal Antibody in Pharmacokinetic Assessment is Modulated by Affinity, Incubation Time, and Bioanalytical Platform

Melody Y. Pai, T. Thway, M. Ma, 2015, The AAPS Journal.

STAT3 Signaling in Polycystic Kidney Disease.

T. Weimbs, J. Talbot, 2013, Drug discovery today. Disease mechanisms.

Mechanism underlying inherited renal cystic diseases STAT 3 signaling in polycystic kidney disease

T. Weimbs, J. Talbot, 2014 .